ImmuPharma plc (AIM:IMM)
London · Delayed Price · Currency is GBP · Price in GBX 4.700
+0.300 (6.82%)
Jun 16, 2026, 11:12 AM GMT
ImmuPharma Market Cap
ImmuPharma has a market cap or net worth of 27.45 million as of June 16, 2026. Its market cap has increased by 107.69% in one year.
Market Cap
27.45M
Enterprise Value
26.10M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.70
Market Cap Chart
Since February 22, 2006, ImmuPharma's market cap has decreased from 36.11M to 27.45M, a decrease of -23.98%. That is a compound annual growth rate of -1.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 27.45M | -11.92% |
| Dec 31, 2025 | 31.17M | 521.13% |
| Dec 31, 2024 | 5.02M | -27.71% |
| Dec 29, 2023 | 6.94M | 13.16% |
| Dec 30, 2022 | 6.13M | -62.85% |
| Dec 31, 2021 | 16.51M | -50.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ondine Biomedical | 67.54M |
| hVIVO | 58.05M |
| Hemogenyx Pharmaceuticals | 56.13M |
| Poolbeg Pharma | 54.29M |
| Sareum Holdings | 31.87M |
| Arecor Therapeutics | 23.60M |
| SkinBioTherapeutics | 22.03M |
| IXICO | 18.86M |